Log in

Relevant bibliographies by topics / Cardiovascular screening / Journal articles

To see the other types of publications on this topic, follow the link: Cardiovascular screening.

Journal articles on the topic 'Cardiovascular screening'

Author: Grafiati

Published: 19 May 2023

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Cardiovascular screening.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Thompson, Paul D., and Carl Sherman. "Cardiovascular Screening." Physician and Sportsmedicine 24, no. 6 (1996): 47–106. http://dx.doi.org/10.3810/psm.1996.06.1375.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Thompson, Paul D., and Carl Sherman. "Cardiovascular Screening." Physician and Sportsmedicine 24, no. 6 (1996): 47–106. http://dx.doi.org/10.1080/00913847.1996.11947967.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Bierig, S. Michelle, Anita Arnold, Lynne C. Einbinder, Eric Armbrecht, and Thomas Burroughs. "Cardiovascular Ultrasound Combined With Non-invasive Screening for the Detection of Undiagnosed Cardiovascular Disease: A Literature Review." Journal of Diagnostic Medical Sonography 34, no. 3 (2017): 197–206. http://dx.doi.org/10.1177/8756479317737764.

Full text

Abstract:

Non-invasive screenings have been widely utilized in the United States and worldwide to provide early identification of cardiovascular disease, allowing for earlier diagnosis and treatment. Screening sonography detects valve disease, cardiac dysfunction, and carotid disease in 5% to 20% of the population. This review discusses the current data regarding cardiovascular screening, the methodologies, and the resources required for performance of screenings. Cardiac and carotid sonography is highly accurate and discovers cardiovascular diseases that impact quality of life and risk of future events

APA, Harvard, Vancouver, ISO, and other styles

4

Herbert, David L. "Preparticipation Cardiovascular Screening." Physician and Sportsmedicine 25, no. 3 (1997): 112–17. http://dx.doi.org/10.3810/psm.1997.03.1242.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Duffy, Jennifer Y., and Afshan B. Hameed. "Cardiovascular disease screening." Seminars in Perinatology 39, no. 4 (2015): 264–67. http://dx.doi.org/10.1053/j.semperi.2015.05.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Seto, Craig K. "Preparticipation cardiovascular screening." Clinics in Sports Medicine 22, no. 1 (2003): 23–35. http://dx.doi.org/10.1016/s0278-5919(02)00040-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Bierig, S. Michelle, Anita Arnold, Lynne C. Einbinder, Eric Armbrecht, and Thomas Burroughs. "Unrecognized Cardiovascular Abnormalities Detected Through a Community Cardiovascular Screening Program." Journal of Diagnostic Medical Sonography 36, no. 3 (2020): 234–42. http://dx.doi.org/10.1177/8756479320905836.

Full text

Abstract:

Objective: Self-referral community cardiovascular screening programs (CCSPs) have a potential to reduce outcome events through early detection of disease. This study evaluated the characteristics of a population that could predict a positive test. Materials and Methods: Participants who completed a cardiovascular screening protocol were compared. The screening protocol included a blood pressure (BP), Doppler ankle brachial index (ABI) testing, a limited carotid sonogram, a limited aortic sonogram, electrocardiogram (ECG), and limited transthoracic echocardiogram (TTE). Results: Screenings were

APA, Harvard, Vancouver, ISO, and other styles

8

Takahashi, Atsuhiko, and Toshio Kushiro. "Update cardiovascular screening methods." Health Evaluation and Promotion 38, no. 6 (2011): 737–43. http://dx.doi.org/10.7143/jhep.38.737.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Yoshinaga, Masao. "School-Based Cardiovascular Screening." Pediatric Cardiology and Cardiac Surgery 29, no. 5 (2013): 212–17. http://dx.doi.org/10.9794/jspccs.29.212.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Kim, Yong-Lim. "Cardiovascular Screening before Transplantation." Journal of the Korean Society for Transplantation 25, no. 4 (2011): 225. http://dx.doi.org/10.4285/jkstn.2011.25.4.225.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Berg, John Erik. "Screening for cardiovascular risk." Journal of Cardiovascular Risk 2, no. 5 (1995): 441???448. http://dx.doi.org/10.1097/00043798-199510000-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Stajic, Zoran, and Zdravko Mijailovic. "Cardiovascular screening of athletes." Vojnosanitetski pregled 66, no. 12 (2009): 1005–9. http://dx.doi.org/10.2298/vsp0912005s.

Full text

Abstract:

<Zakljucak> Sprovodjenje kardiovaskularnog skrining programa ima za cilj smanjenje ucestalosti iznenadne srcane smrti kod sportista. Potrebno je doneti nacionalne preporuke koje bi trebalo da jasno definisu obim, organizaciju i sprovodjenje skrininga i redovnih sistematskih pregleda sportista. U medjuvremenu, dok se ne donesu posebne nacionalne preporuke, smatramo da je neophodno da se svi klinicki lekari koji se bave sportskom medicinom detaljno upoznaju sa vazecim evropskim i americkim preporukama, a za prakticnu primenu u svakodnevnoj rutinskoj klinickoj praksi predlazemo primenu modi

APA, Harvard, Vancouver, ISO, and other styles

13

Frolkis, Joseph P. "SCREENING FOR CARDIOVASCULAR DISEASE." Medical Clinics of North America 83, no. 6 (1999): 1339–73. http://dx.doi.org/10.1016/s0025-7125(05)70170-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Mou, Margaret, and Don P. Wilson. "Cardiovascular Screening in Youth*†." Journal of Clinical Lipidology 9, no. 3 (2015): 443–44. http://dx.doi.org/10.1016/j.jacl.2015.03.055.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Beckerman, James, Paul Wang, and Mark Hlatky. "Cardiovascular Screening of Athletes." Clinical Journal of Sport Medicine 14, no. 3 (2004): 127–33. http://dx.doi.org/10.1097/00042752-200405000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

WIERZBICKI, A. "Screening for cardiovascular disease." European Heart Journal 25, no. 11 (2004): 996. http://dx.doi.org/10.1016/j.ehj.2004.02.031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Maron, Barry J., Bo Gregers Winkel, and Jacob Tfelt-Hansen. "Perspectives on Cardiovascular Screening." JAMA 313, no. 1 (2015): 31. http://dx.doi.org/10.1001/jama.2014.16253.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Gupta, Sanjaya, Timir Baman, and Sharlene M. Day. "Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening." Sports Health: A Multidisciplinary Approach 1, no. 6 (2009): 500–507. http://dx.doi.org/10.1177/1941738109350405.

Full text

Abstract:

Context: Identification of potentially fatal cardiac conditions in otherwise healthy athletes presents a major challenge to the sports medicine community. The requirements for preparticipation screening vary among countries and even from state to state within the United States. The mandated use of an electrocardiogram as a screening implement has provoked international controversy. Evidence acquisition: Part 1 of this review highlights the current guidelines and controversies surrounding cardiovascular screening, with a focus on the diagnostic challenges associated with identifying athletes wi

APA, Harvard, Vancouver, ISO, and other styles

19

Gonzales, Boris, Miguel Ángel Bayo, Carmen Garcia, et al. "Screening cardiovascular pretrasplante y riesgo cardiovascular postrasplante." Diálisis y Trasplante 36, no. 2 (2015): 61–62. http://dx.doi.org/10.1016/j.dialis.2015.04.033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Kóródi, Gyula. "Health Screening Examinations in Cardiovascular Risk Estimation." Academic and Applied Research in Military and Public Management Science 12, no. 1 (2013): 39–43. http://dx.doi.org/10.32565/aarms.2013.1.4.

Full text

Abstract:

The most important elements in prevention of cardiovascular (and cerebrovascular) dis- eases are screening and managing the risk factors, such as high blood pressure, high total cholesterol or high blood glucose etc.. The best way to find out the personal specific risk profile is through screening tests during annual doctor visits. Regular cardiovascu- lar and cerebrovascular screenings are very important because they help detect the risk factors in their earliest and asymptomatic stages. This way, the patients can treat their risk factors with lifestyle changes and pharmacotherapies, if appro

APA, Harvard, Vancouver, ISO, and other styles

21

Lagerweij, GR, L. Brouwers, GA De Wit, et al. "Impact of preventive screening and lifestyle interventions in women with a history of preeclampsia: A micro-simulation study." European Journal of Preventive Cardiology 27, no. 13 (2020): 1389–99. http://dx.doi.org/10.1177/2047487319898021.

Full text

Abstract:

Background Preeclampsia is a female-specific risk factor for the development of future cardiovascular disease. Whether early preventive cardiovascular disease risk screenings combined with risk-based lifestyle interventions in women with previous preeclampsia are beneficial and cost-effective is unknown. Methods A micro-simulation model was developed to assess the life-long impact of preventive cardiovascular screening strategies initiated after women experienced preeclampsia during pregnancy. Screening was started at the age of 30 or 40 years and repeated every five years. Data (initial and f

APA, Harvard, Vancouver, ISO, and other styles

22

Asif, Irfan M., and Jonathan A. Drezner. "Cardiovascular Screening in Young Athletes." Current Sports Medicine Reports 15, no. 2 (2016): 76–80. http://dx.doi.org/10.1249/jsr.0000000000000247.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Hamel, Leslie, and Kathleen Oberle. "Cardiovascular Risk Screening for Women." Clinical Nurse Specialist 10, no. 6 (1996): 275–79. http://dx.doi.org/10.1097/00002800-199611000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

SHERMAN-BROWN, ALICE, and AFSHAN B. HAMEED. "Cardiovascular Disease Screening in Pregnancy." Clinical Obstetrics & Gynecology 63, no. 4 (2020): 808–14. http://dx.doi.org/10.1097/grf.0000000000000565.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Siddiqui, Saad, and Dilip R. Patel. "Cardiovascular Screening of Adolescent Athletes." Pediatric Clinics of North America 57, no. 3 (2010): 635–47. http://dx.doi.org/10.1016/j.pcl.2010.03.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Dadlani, Gul H., Coralis Mercado, Val Roberts, et al. "Cardiovascular screening in Williams syndrome." Progress in Pediatric Cardiology 58 (September 2020): 101267. http://dx.doi.org/10.1016/j.ppedcard.2020.101267.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Steinberger, Julia. "School screening for cardiovascular risk." Journal of Pediatrics 208 (May 2019): 1–2. http://dx.doi.org/10.1016/j.jpeds.2019.03.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Sigler, M., T. Paul, and R. G. Grabitz. "Biocompatibility screening in cardiovascular implants." Zeitschrift für Kardiologie 94, no. 6 (2005): 383–91. http://dx.doi.org/10.1007/s00392-005-0231-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Guthrie, B. "Screening for cardiovascular risk factors." BMJ 307, no. 6895 (1993): 65. http://dx.doi.org/10.1136/bmj.307.6895.65.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Smolderen, Kim G., Annelies E. Aquarius, and Johan Denollet. "Depression and Screening Cardiovascular Events." Journal of General Internal Medicine 23, no. 9 (2008): 1543. http://dx.doi.org/10.1007/s11606-008-0696-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

EMPANA, J. "Screening for cardiovascular disease: reply." European Heart Journal 25, no. 11 (2004): 996–97. http://dx.doi.org/10.1016/j.ehj.2004.02.032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Drezner, Jonathan A., Jordan M. Prutkin, Kimberly G. Harmon, et al. "Cardiovascular Screening in College Athletes." Journal of the American College of Cardiology 65, no. 21 (2015): 2353–55. http://dx.doi.org/10.1016/j.jacc.2015.02.072.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Harmon, Kimberly G., and Jonathan A. Drezner. "Cardiovascular Screening for Young Athletes." JAMA 313, no. 16 (2015): 1673. http://dx.doi.org/10.1001/jama.2015.3231.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Niebauer, Josef, Domenico Corrado, and Antonio Pelliccia. "Cardiovascular Screening for Young Athletes." JAMA 313, no. 16 (2015): 1674. http://dx.doi.org/10.1001/jama.2015.3234.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Newell, Bradley, Ashley Kells, Amy Robertson, et al. "Identifying Opportunities for Impact of Community-Based Pharmacist-Led Biometric Health Screenings on ASCVD Risk." Kansas Journal of Medicine 16, no. 1 (2023): 88–93. http://dx.doi.org/10.17161/kjm.vol16.18514.

Full text

Abstract:

Introduction. Community-based pharmacists are uniquely positioned to assist in the early detection of underlying cardiovascular disease (CVD) as it affects approximately 50% of adults in the United States. To facilitate discussion between providers and patients, the 2013 Atherosclerotic Cardiovascular (ASCVD) Risk Estimator Plus was created to calculate a patient’s cardiovascular risk for primary prevention. Organizations utilize annual biometric health screenings to help employees identify health risks previously undetected. The goal of this study was to evaluate how community-based pharmacis

APA, Harvard, Vancouver, ISO, and other styles

36

Nolan, Timiya S., Songzhu Zhao, Amaris Williams, et al. "Abstract A139: Examining the association of cardiovascular health attainment with cancer screening adherence in community-dwelling Black women." Cancer Epidemiology, Biomarkers & Prevention 32, no. 12_Supplement (2023): A139. http://dx.doi.org/10.1158/1538-7755.disp23-a139.

Full text

Abstract:

Abstract Purpose of the study Cancer and cardiovascular disease are leading causes of death in the United States and share modifiable risk factors. Increasing ideal cardiovascular health indicated by the American Heart Association’s Life’s Simple 7 metrics (LS7: blood pressure, glucose, cholesterol, body mass index, physical activity, and smoking) and cancer screening adherence are both associated with reducing cancer-related mortality. However, there have been no studies to identify associations between LS7 and cancer screening adherence. It is well documented that people adopting positive he

APA, Harvard, Vancouver, ISO, and other styles

37

Wen, Dennis Y. "Preparticipation Cardiovascular Screening of Young Athletes." Physician and Sportsmedicine 32, no. 6 (2004): 23–30. http://dx.doi.org/10.3810/psm.2004.06.387.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Wen, Dennis Y. "Preparticipation Cardiovascular Screening off Young Athletes." Physician and Sportsmedicine 33, no. 12 (2005): 31–42. http://dx.doi.org/10.3810/psm.2005.12.274.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

&NA;. "Cardiovascular Preparticipation Screening of Competitive Athletes." Medicine &amp Science in Sports &amp Exercise 28, no. 12 (1996): 1445–52. http://dx.doi.org/10.1097/00005768-199612000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Barker, D., S. Barber, KM Birch, and LB Tan. "Cardiovascular screening of asymptomatic postmenopausal women." European Journal of Cardiovascular Prevention & Rehabilitation 13, Supplement 1 (2006): S65—S66. http://dx.doi.org/10.1097/00149831-200605001-00265.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Panhuyzen-Goedkoop, N. M. "Preparticipation cardiovascular screening in young athletes." British Journal of Sports Medicine 43, no. 9 (2009): 629–30. http://dx.doi.org/10.1136/bjsm.2009.064220.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Asif, Irfan M., Jonathan A. Drezner, and Francis G. O’Connor. "Cardiovascular Preparticipation Screening in Young Athletes." Sports Health: A Multidisciplinary Approach 9, no. 1 (2016): 19–21. http://dx.doi.org/10.1177/1941738116680188.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Bultas, Margaret W. "Understanding Sports Preparticipation Cardiovascular Screening Recommendations." NASN School Nurse 27, no. 6 (2012): 318–22. http://dx.doi.org/10.1177/1942602x12453336.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Maron, Barry J., Paul D. Thompson, James C. Puffer, et al. "Cardiovascular Preparticipation Screening of Competitive Athletes." Circulation 94, no. 4 (1996): 850–56. http://dx.doi.org/10.1161/01.cir.94.4.850.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Zão, Ana, Sandra Magalhães, and Mário Santos. "Frailty in cardiovascular disease: Screening tools." Revista Portuguesa de Cardiologia (English Edition) 38, no. 2 (2019): 143–58. http://dx.doi.org/10.1016/j.repce.2018.05.016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Sullivan, David R. "Screening for cardiovascular disease with cholesterol." Clinica Chimica Acta 315, no. 1-2 (2002): 49–60. http://dx.doi.org/10.1016/s0009-8981(01)00720-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Zão, Ana, Sandra Magalhães, and Mário Santos. "Frailty in cardiovascular disease: Screening tools." Revista Portuguesa de Cardiologia 38, no. 2 (2019): 143–58. http://dx.doi.org/10.1016/j.repc.2018.05.019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Jurkowski, Janine M. "Nativity and Cardiovascular Disease Screening Practices." Journal of Immigrant and Minority Health 8, no. 4 (2006): 339–46. http://dx.doi.org/10.1007/s10903-006-9004-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Morris, Charles K., and Victor F. Froelicher. "Cardiovascular Screening for High Altitude Trekking." Clinical Journal of Sport Medicine 1, no. 2 (1991): 100–103. http://dx.doi.org/10.1097/00042752-199104000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Seto, Craig K., and Michael E. Pendleton. "Preparticipation Cardiovascular Screening in Young Athletes." Current Sports Medicine Reports 8, no. 2 (2009): 59–64. http://dx.doi.org/10.1249/jsr.0b013e31819ccdaf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!